Q4 2025 Holdings
Filed 2026-02-17 | 30 holdings | $2.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $604.8M | 22,970,388 | 27.4% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $382.0M | 7,880,094 | 17.3% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $290.1M | 1,706,469 | 13.2% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $199.6M | 4,288,120 | 9.1% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $77.9M | 3,115,000 | 3.5% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $72.9M | 1,389,276 | 3.3% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $67.0M | 2,123,604 | 3.0% |
| Immunome Inc(IMNM) | COM | 45257U108 | $61.3M | 2,855,590 | 2.8% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $55.0M | 6,728,116 | 2.5% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $54.5M | 1,667,119 | 2.5% |
| Xencor Inc(XNCR) | COM | 98401F105 | $49.8M | 3,251,112 | 2.3% |
| Bridgebio Oncology Therapeut(BBOT) | COM NEW | 107924102 | $35.3M | 2,823,126 | 1.6% |
| Eton Pharmaceuticals Inc(ETON) | COM | 29772L108 | $34.3M | 2,030,544 | 1.6% |
| CG Oncology Inc(CGON) | COM | 156944100 | $32.1M | 772,000 | 1.5% |
| Zenas Biopharma Inc(ZBIO) | COM | 98937L105 | $28.7M | 789,500 | 1.3% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $26.2M | 1,271,342 | 1.2% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $23.3M | 334,380 | 1.1% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $20.8M | 450,000 | 0.9% |
| Aquestive Therapeutics Inc(AQST) | COM | 03843E104 | $17.0M | 2,625,000 | 0.8% |
| Voyager Therapeutics Inc(VYGR) | COM | 92915B106 | $15.7M | 4,002,847 | 0.7% |
| CG Oncology Inc(CGON)Call | COM | 156944100 | $12.2M | 292,800 | 0.6% |
| Atara Biotherapeutics Inc(ATRA) | COM NEW | 046513206 | $10.4M | 573,183 | 0.5% |
| Mannkind Corp(MNKD) | COM NEW | 56400P706 | $9.4M | 1,660,000 | 0.4% |
| Nuvation BIO Inc(NUVB/WS) | *W EXP 02/10/202 | 67080N119 | $8.6M | 963,333 | 0.4% |
| Evolus Inc(EOLS) | COM | 30052C107 | $4.5M | 675,000 | 0.2% |
| Ibio Inc(IBIO) | COM NEW | 451033708 | $4.3M | 2,228,000 | 0.2% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $3.3M | 7,856,466 | 0.1% |
| Camp4 Therapeutics Corp(CAMP) | COM | 13463J101 | $2.0M | 325,000 | 0.1% |
| Xencor Inc(XNCR)Call | COM | 98401F105 | $1.0M | 67,500 | 0.0% |
| Surrozen Inc(SRZNW) | *W EXP 08/01/203 | 86889P117 | $100.4K | 4,444 | 0.0% |